IBI-362

· Innovent Biologics (Suzhou) Co. Ltd.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for IBI-362, covering 2024-08-27 to 2024-11-12. Get the full timeline:

Most recent: Clinical Trial Update: A Study of IBI362 in Participants With Obesity or Overweight [Phase 3]